biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > Looking for a great week starting tomorrow..

<< Previous

Bullboard Posts

Next >>

Comment by ronrydellon Jun 14, 2021 11:22am

190 Views

Post# 33381580

RE:RE:RE:RE:RE:Looking for a great week starting tomorrow..

Not the best time to be involved in profit taking....especially in the next two weeks....buyers start your engines as we have dropped, both in the states and in Canada....however...the volume is up and it's still early in the day....We will be getting data and people need to stay in and see the "on the river card" to win the day!

<< Previous

Bullboard Posts

Next >>

Soma Gold poised to extend profitable track record